# Talapo Therapeutics, Inc. — Form D

Talapo Therapeutics, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-12-12. The offering totals $800K, of which $100K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-12-12
- Form: D
- Accession: 0001725002-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $100K
- Remaining: $700K
- Investors: 3
- Date of first sale: 2017-11-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300507

## Issuer

- Name: Talapo Therapeutics, Inc.
- CIK: 0001725002
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 2223 AVENIDA DE LA PLAYA, LA JOLLA, CA, 92037
- Phone: 858-754-3201

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Craig Harding | Director | La Jolla, CA |
| Erik Martinez-Hackert | Director | La Jolla, CA |
| Davorka Messmer | Director | La Jolla, CA |
| Neil Senturia | Director | La Jolla, CA |
| Davorka Messmer | Executive Officer | La Jolla, CA |
| Neil Senturia | Executive Officer | La Jolla, CA |

## More

- [CIK 1725002 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1725002&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001725002-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.